Analysis of CD38 and CD95 coexpression with LRs in PBMCs from 12 active SLE patients and 11 healthy controls revealed a significant increased LRs expression on CD38+ B cells in SLE patients compared with healthy controls (Figure 1(b)). This evidence concerns the gene FAS and systemic lupus erythematosus.